Trials / Unknown
UnknownNCT05251792
Macular Pigment Optical Density in Primary Angle-closure Disease
Study on the Relationship Between Macular Pigment Optical Density and Primary Angle-closure Disease
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Zhongshan Ophthalmic Center, Sun Yat-sen University · Academic / Other
- Sex
- All
- Age
- 40 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
Glaucoma is the leading cause of irreversible blindness in the world, and primary angle-closure glaucoma (PACG) is the most important type of glaucoma in Asia. Primary angle closure disease (PACD) is a group of diseases related to PACG, and the pathogenesis is still unclear. Macular pigment has the functions of filtering short-wavelength waves and anti-oxidation, which are related to visual function. Previous studies have found that the macular pigment density (MPOD) is significantly reduced in primary open-angle glaucoma. This project uses the single-wavelength reflection method to measure MPOD, observes the characteristics of PACD and the normal control group's changes in retinal MPOD, and explains the relationship between PACD's MPOD changes and angle-closure glaucoma optic nerve damage
Detailed description
Observation index: Visual acuity,Intraocular pressure,Ophthalmoscope,MPOD,Visual field and OCT. Inspection parameters of OCT: 1. Retinal nerve fiber layer thickness 2. Ganglion cell complex thickness 3. Mean thickness of the central retina 4. Mean defect
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Ocular examination | All participants underwent a detailed examination, including visual acuity, slit lamp biomicroscopy, direct ophthalmoscopy, optometry noncontact tonometry,MPOD measurement and optical coherence tomography (OCT) measurement |
Timeline
- Start date
- 2021-11-11
- Primary completion
- 2024-03-30
- Completion
- 2024-12-30
- First posted
- 2022-02-23
- Last updated
- 2023-02-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05251792. Inclusion in this directory is not an endorsement.